Clinical Trials Browser

Phase 2 × Hodgkin Disease × itacitinib × Clear all

NCT02456675 2018-01-12

INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Terminated

Hodgkin Disease